103
Participants
Start Date
October 31, 1997
Study Completion Date
December 31, 2002
Nelfinavir mesylate
Efavirenz
Metropolitan Hosp. Ctr., New York
Harlem Hosp. Ctr. NY NICHD CRS, New York
Bronx-Lebanon Hosp. IMPAACT CRS, The Bronx
SUNY Downstate Med. Ctr., Children's Hosp. at Downstate NICHD CRS, Brooklyn
Howard Univ. Washington DC NICHD CRS, Washington D.C.
Univ. of Maryland Med. Ctr., Div. of Ped. Immunology & Rheumatology, Baltimore
Univ. of Florida Jacksonville NICHD CRS, Jacksonville
Univ. of Mississippi Med. Ctr Children's Hosp., Jackson
Tulane/LSU Maternal/Child CRS, New Orleans
Long Beach Memorial Med. Ctr., Miller Children's Hosp., Long Beach
The Children's Hosp. of Philadelphia IMPAACT CRS, Philadelphia
UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS, Los Angeles
Usc La Nichd Crs, Los Angeles
Children's Hosp. & Research Ctr. Oakland, Ped. Clinical Research Ctr. & Research Lab., Oakland
UCSD Maternal, Child, and Adolescent HIV CRS, San Diego
Harbor - UCLA Med. Ctr. - Dept. of Peds., Div. of Infectious Diseases, Torrance
NYU Med. Ctr., Dept. of Medicine, New York
Nyu Ny Nichd Crs, New York
St. Christopher's Hosp. for Children, Philadelphia
St. Jude/UTHSC CRS, Memphis
Texas Children's Hosp. CRS, Houston
Seattle Children's Hospital CRS, Seattle
UW School of Medicine - CHRMC, Seattle
HMS - Children's Hosp. Boston, Div. of Infectious Diseases, Boston
WNE Maternal Pediatric Adolescent AIDS CRS, Worcester
Univ. of Puerto Rico Ped. HIV/AIDS Research Program CRS, San Juan
San Juan City Hosp. PR NICHD CRS, San Juan
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
National Institute of Allergy and Infectious Diseases (NIAID)
NIH